TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
NBIX

Neurocrine Biosciences Inc

Healthcare · Drug Manufacturers - Specialty & Generic

142.40$ +0.8% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Neurocrine Biosciences Inc (NBIX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 5,359 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NBIX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
399 365 289 754 772 818 806 841 934 993 958 1,067 1,180 1,306 1,362 1,516 1,503 1,735 1,846 1,956 2,017 2,073 2,145 2,006 2,143 2,369 2,360 2,613 2,848 3,251 3,472 3,305 3,535 3,719 3,688 3,890 4,266 4,632 4,906 5,359
358 310 239 537 548 555 514 568 714 738 633 749 819 831 968 1,146 1,157 1,016 1,085 1,110 1,006 973 1,018 1,019 1,206 1,454 1,433 1,497 1,650 1,607 1,799 1,670 1,877 1,725 1,638 1,749 2,158 2,523 2,436 1,638
100 83 64 309 268 255 175 166 196 142 73 141 167 112 187 415 425 187 353 368 311 341 270 163 212 263 104 160 294 251 396 140 349 233 194 264 340 713 267 332
353 307 236 525 511 516 460 509 635 651 524 620 670 671 772 948 945 801 874 885 766 711 665 648 799 989 895 977 1,095 1,032 1,211 1,039 1,228 1,076 944 976 1,115 1,480 1,316 390
– – – 6.1 30 31 45 43 54 56 72 95 115 127 149 148 157 157 148 159 164 186 264 279 301 350 392 388 418 439 451 468 481 479 516 596 728 687 768 887
0.0 0.0 0.0 0.1 0.2 -31 0.0 0.0 6.1 11 13 12 11 17 21 22 21 28 30 28 26 31 29 29 37 35 33 32 29 38 37 43 46 57 59 57 69 69 65 104
6.2 6.3 7.1 7.0 9.1 11 12 19 29 34 37 40 40 42 42 45 43 45 45 150 149 59 64 67 61 59 63 66 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – 5.4 – – – 5.8 – 5.7 6.1 3.7 – – – – – 501
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – 37 37 37 35 36 34 34 35 37 36 37 36 – – 2,226
48 50 42 409 425 445 442 464 486 512 548 583 605 669 662 684 698 609 641 677 671 699 753 582 599 661 675 760 846 1,019 1,086 796 816 1,129 1,152 1,196 1,262 1,378 1,499 1,666
27 30 24 28 38 54 46 62 456 88 72 101 116 565 140 573 611 187 190 213 226 246 254 286 485 538 374 583 692 655 713 399 430 508 523 546 638 743 832 875
14 15 12 361 365 38 374 379 384 62 3.3 – – 409 – 420 425 94 770 120 289 225 17 17 187 169 18 187 188 170 259 35 35 – – – 51 – – –
1.7 5.1 0.9 27 37 5.6 46 61 62 14 68 95 102 46 126 137 171 39 172 191 206 52 236 266 298 67 356 392 94 133 87 107 96 100 110 105 120 105 120 142
0.0 0.0 0.0 361 365 370 374 379 0.0 388 393 398 404 409 414 – – 318 322 326 331 335 378 169 – – 170 – – – – – – – – – – – – –
352 315 247 345 348 372 364 377 448 481 409 484 575 637 700 831 804 1,126 1,206 1,279 1,346 1,374 1,391 1,423 1,545 1,708 1,685 1,853 2,002 2,232 2,386 2,509 2,719 2,590 2,536 2,694 3,004 3,253 3,407 3,694
-1,012 -1,056 -1,135 -1,195 -1,206 -1,199 -1,241 -1,247 -1,196 -1,178 -1,272 -1,220 -1,167 -1,133 -1,095 -1,016 -1,073 -725 -693 -651 -629 -636 -547 -564 -496 -407 -483 -388 -305 -157 -114 -49 81 29 -5.3 85 294 448 590 724
87 87 87 88 88 93 90 90 97 96 91 95 96 97 97 98 93 97 98 98 98 95 98 96 99 101 97 100 101 102 104 104 104 103 103 101 103 103 103 104

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?